Targeting cancer neoantigens: A promising source of immunogens for cancer immunotherapy
Dr. Philip Arlen to Speak at World Vaccine Congress Europe Topic: Targeting cancer neoantigens: A promising source...
12Oct
17Aug
Dr. Philip Arlen to Speak at Immuno-Oncology Summit
Dr. Philip Arlen to Speak at Immuno-Oncology Summit - The Summit will return to Boston on...
05Jun
Dr. Philip Arlen to Speak at ASCO Annual Meeting
Dr. Philip Arlen to Speak at ASCO Annual Meeting - June 2-6, 2017 | McCormick Place...
19Apr
Read more...
19Apr
Dr. Philip Arlen to Speak at the Biomarkers & Immuno-Oncology World Congress 2017
Monoclonal Antibodies Targeting Novel Immunogenic Neo-Epitopes for the Treatment of Solid Tumors May 2-4, 2017, Philadelphia Marriott...
02Apr
Precision Biologics to Highlight Preclinical Data on NEO-201, a Neoantigen Targeting Antibody in Oral Presentation at the 110th Annual Meeting of the American Association of Clinical Research
Rockville, MD, April 2, 2017 - Precision-Biologics Inc.
03Mar
Immuno-Oncology Breakthroughs – Novel Cancer Therapies
Dr. Philip Arlen to Speak at Immuno-Oncology Breakthroughs - Novel Cancer Therapies at the Noblecon...
01Feb
ImmunoTX Summit
Dr. Philip Arlen to Speak at ImmunoTX Summit - The Discovery and Development of Novel...
29Sep
Dr. Philip Arlen to Speak at Biomarkers & Precision Medicine USA Congress
Dr. Philip Arlen to Speak at Biomarkers & Precision Medicine USA Congress - 3-4 October 2016,...
29Sep
Dr. Philip Arlen to Speak at Immune Profiling World Congress
Dr. Philip Arlen to Speak at Immune Profiling World Congress – 11-12 October 2016, Fairmont...